NCT07127536 Effects of the CO-OP Approach on Occupational Performance and Executive Function in Adults With Stroke
| NCT ID | NCT07127536 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2024-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to use the Cognitive Orientation to Daily Occupational Performance (CO-OP) approach with people who have experienced a stroke. This method helps individuals improve how they perform daily tasks by teaching them problem-solving strategies. This study will answer the following main questions: Does the CO-OP approach help participants perform their daily activities more easily? Does the CO-OP approach support thinking skills such as planning and attention? Researchers will look at changes in participants' daily activity performance and thinking skills before and after the CO-OP sessions. Participants will be randomly assigned to one of two groups: Complete simple tests before and after the sessions Practice real-life daily activities that are meaningful to them Intervention group: Will receive standard occupational therapy plus CO-OP sessions. The CO-OP sessions will take place 5 days a week for 4 weeks, with each session lasting 45 minutes. Control group: Will receive only standard occupational therapy as part of usual care.
Eligibility Criteria
Inclusion Criteria: * Being in the subacute phase after stroke (3 months \< stroke onset \< 2 years) * First-ever stroke * Brunnstrom stage 2 or above * Ability to read and write * Receiving rehabilitation services at Ankara Etlik City Hospital, Physical Medicine and Rehabilitation Hospital Exclusion Criteria: * Having any orthopedic, psychological, or neurological disorder other than stroke * Having moderate to severe aphasia * Having cognitive impairment (Mini-Mental State Examination score ≤ 24) * Not willing to participate in the study
Frequently Asked Questions
Who can join the NCT07127536 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07127536 currently recruiting?
Yes, NCT07127536 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hacettepe University to inquire about joining.
Where is the NCT07127536 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07127536 clinical trial?
NCT07127536 is sponsored by Hacettepe University. The trial plans to enroll 66 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.